Stokes Frank sold CSTL
March 5, 2026 · Form 4 insider transaction
Stokes Frank sold 6,001 shares of Castle Biosciences, Inc. at $27.98 per share, a transaction worth $167.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Frank Stokes on November 13, 2025.; This transaction was executed in multiple trades at prices ranging from $27.51 to $28.41, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.